Evidence map›Paper›PMID 42469001›Full record

ArticleOpen heart2026

Comparative performance of stroke risk scores in patients with atrial fibrillation with low stroke risk.

Nicolas Zubrzycki, Karice Hyun, Erdahl Teber, Boroumand Farzaneh, Austin Chin Chwan Ng, Ben Freedman, David B Brieger

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Open heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas ZubrzyckiSt Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia nzubrz@gmail.com.ORCID http://orcid.org/0000-0002-0099-4119
Karice HyunThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-0164-7725
Erdahl TeberThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Boroumand FarzanehThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Austin Chin Chwan NgCardiology, Concord Hospital and The University of Sydney, Concord, New South Wales, Australia.
Ben FreedmanCharles Perkins Centre, Heart Research Institute, University of Sydney, Sydney, New South Wales, Australia.
David B BriegerCardiology, ANZAC Research Institute Concord Repatriation General Hospital, Concord, New South Wales, Australia.ORCID http://orcid.org/0000-0001-6115-0326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAustralian guidelines recommend the CHA

methodsWe conducted a population-based cohort study using linked data from the New South Wales Admitted Patient Data Collection, the National Death Index and the Pharmaceutical Benefits Scheme databases. Oral anticoagulant-naïve patients with a first hospital admission for AF between July 2003 and January 2021 were included. Patients were followed for ≥12 months and classified into low-risk, intermediate-risk or high-risk categories for each score. 'Truly low-risk' was defined as annual ischaemic stroke incidence <0.9%. Predictive accuracy was assessed using the concordance-statistic.

resultsAmong 224 451 eligible patients, 3552 (1.6%) were hospitalised for ischaemic stroke within 12 months. The proportion labelled low-risk ranged from 2.0% (Modified-CHADS

conclusionsThe guideline-endorsed CHA

Indexed as

Atrial FibrillationStrokeAgedAged, 80 and overAnticoagulantsFemaleFollow-Up StudiesHumansIncidenceMaleNew South WalesRetrospective StudiesRisk AssessmentRisk FactorsAnticoagulantsAtrial FibrillationRISK FACTORSSTROKE

Identifiers

PMID42469001
PMCPMC13384152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.